Definition of a COS for disease overarching therapies such as ATMPs or targeted therapies

Definition of a COS for disease overarching therapies such as ATMPs or targeted therapies a focus will be provided on a COS for novel CD19 CAR T cell products as well as one novel targeted approach eg ibrutinib or venetoclax M18 outcome measures for these COS will include deep omic data